Advanced Biomed, Inc. (ADVB)
4.95
-0.19
(-3.70%)
USD |
NASDAQ |
Oct 15, 12:26
Advanced Biomed Debt to Equity Ratio : 0.0877 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0877 |
| March 31, 2026 | 0.0805 |
| December 31, 2025 | 0.0749 |
| September 30, 2025 | 0.5659 |
| June 30, 2025 | 0.0202 |
| March 31, 2025 | 0.0442 |
| December 31, 2024 | 0.4656 |
| September 30, 2024 | 0.1156 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.6562 |
| September 30, 2023 | 0.2249 |
| June 30, 2023 | 0.1814 |
| March 31, 2023 | 0.1252 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.1346 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| SBC Medical Group Holdings, Inc. | 0.1828 |
| Abbott Laboratories | 0.638 |
| Acme United Corp. | 0.3172 |
| Align Technology, Inc. | 0.0286 |
| AngioDynamics, Inc. | 0.0655 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.4316M |
| Total Liabilities (Quarterly) | 0.0463M |
| Shareholders Equity (Quarterly) | 0.3854M |
| Current Ratio | 9.322 |
| Net Debt Paydown Yield | -0.07% |